Subscribe
Pet Health & Wellness
6 min read

Morgan Valentino | Vice President of Design & Construction, VEG ER for Pets

VEG ER for Pets runs real estate, design, and construction as one team, so every site is vetted for cost and infrastructure before the lease is signed. Morgan Valentino explains why VEG's ERs have no reception desk, how a kit-of-parts keeps fast growth from getting expensive, and why hospital layout is a staffing decision as much as a clinical one.

Written by
Roy Ben-Tzvi
Published on
October 27, 2026
Morgan Valentino, Vice President of Design & Construction of VEG ER for Pets
Morgan Valentino, Vice President of Design & Construction of VEG ER for Pets

As Vice President of Design & Construction at VEG ER for Pets, Morgan Valentino has helped scale the organization from a small number of hospitals to a national footprint. In that process, she has developed a distinct approach to veterinary hospital design — one that integrates real estate, design, and construction into a unified operating model, enabling faster execution, stronger site selection discipline, and more consistent experiences across markets.

In our conversation, she explains why openness serves as the guiding principle behind both physical layouts and communication practices, how repeatable design systems reduce friction as organizations scale, and why hospital environments directly shape team performance, customer trust, and patient outcomes.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Pro
Keep Reading

Other Interviews

More conversations with founders, operators, and investors building the future of pet care.

Learn more
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Pet Health & Wellness
17 min read

Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics

Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.

Learn more
Learn more
Brian Cheng | Co-Founder, HOLY CAP
Pet Food & CPG
11 min read

Brian Cheng | Co-Founder, HOLY CAP

HOLY CAP launched in Hong Kong in 2022 selling functional mushroom powders and learned fast that pet owners will not measure another supplement into the bowl. Co-founder Brian Cheng explains the pivot to lickable Squeezees, why in-person sampling beats Amazon at this stage, the operating cost of 14 SKUs split across dogs and cats, and the plan to become a complete-diet brand.

Learn more
Learn more
Dennis Gucker & David Franklin | Co-Founders, PawPay
Pet Tech
10 min read

Dennis Gucker & David Franklin | Co-Founders, PawPay

Fewer than 5% of U.S. pets are insured, and PawPay's co-founders think the failure is operational, not emotional. Dennis Gucker explains what carriers told them about the gap between point of sale and point of care, why the company stayed carrier-agnostic, and how real-time coverage scoring plus point-of-care payment changes what clinics can say yes to.

Learn more
View all interviews